Abcuro abcuro.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Abcuro developing the next generation of bio-therapeutics for the treatment of autoimmunity and cancer. The company aims to develop a new class of immune modulatory bio-therapeutics for treating both autoimmunity and cancer. Abcuro leverages the systematic target validation and clinical insights gained by its founders to identify new targets. Its intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivo validation in diseased tissue has uncovered new...Show all

Abcuro developing the next generation of bio-therapeutics for the treatment of autoimmunity and cancer. The company aims to develop a new class of immune modulatory bio-therapeutics for treating both autoimmunity and cancer. Abcuro leverages the syst...Show all

Company (Alive / Active)

Phone: 401-591-6793

Fax:

90n Bridge Street
Suite 100
Newton, 02458
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Abcuro $2.3M Dec 13, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Abcuro Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)